Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Mechanism Identified Protects Cells from Virulence Factors

By LabMedica International staff writers
Posted on 10 Oct 2017
A team of molecular microbiologists has identified the mechanism that allows some cells to survive invasion by pathogenic bacteria such as species of Yersinia, which cause a range of illness from plague to gastrointestinal disease in humans.

Many pathogens deliver virulence factors or effectors into host cells in order to evade host defenses and establish infection. More...
In the case of Yersinia, this is the protein YopJ, an acetyltransferase that binds to a conserved alpha-helix of MAPK kinases. Although such effector proteins disrupt critical cellular signaling pathways, they also trigger specific anti-pathogen responses, a process termed “effector-triggered immunity.”

Yersinia inactivates critical proteins of the NF-kappaB and MAPK signaling cascade, thereby blocking inflammatory cytokine production but also inducing apoptosis. Yersinia-induced apoptosis requires the kinase activity of receptor-interacting protein kinase 1 (RIPK1), a key regulator of cell death, NF-kappaB, and MAPK signaling.

Investigators at the University of Pennsylvania (Philadelphia, USA) reported in the August 30, 2017, online edition of the Journal of Experimental Medicine that Yersinia-induced apoptosis was critical for host survival, containment of bacteria in granulomas, and control of bacterial burdens in vivo. They demonstrated that this apoptotic response provided a cell-extrinsic signal that promoted optimal innate immune cytokine production and antibacterial defense, demonstrating a novel role for RIPK1 kinase–induced apoptosis in mediating effector-triggered immunity to circumvent pathogen inhibition of immune signaling.

Working with a line of mice that carried a mutated, inactive form of RIPK1, the investigators showed that when these mice were infected with Yersinia, their cells did not undergo apoptosis. Instead, these animals became extremely sensitive to infection, succumbing to an infection that normal mice almost always survived. Bacteria could be found dispersed throughout the body, whereas in normal mice Yersinia was typically confined to the lymph nodes, spleen, and liver.

"RIPK1 sits at a key decision point for the cell," said senior author Dr. Igor E. Brodsky, assistant professor in of pathobiology at the University of Pennsylvania. "Depending on the stimuli the cells see, this protein can transduce a signal to activate gene expression, programmed cell death, or apoptosis, or it can activate another form of cell death called programmed necrosis. In the context of an infection, the cells that are dying are talking to the other cells that are not infected. I do not think of it as altruistic, exactly, but it is a way for the cells that cannot respond any longer to still alert their neighbors that a pathogen is present."

Related Links:
University of Pennsylvania


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Pipette Controller
Sapphire MaxiPette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.